Silexion Therapeutics SLXN
NASDAQ SLXN
$0.28 +0.00 (+0.61%)
At close: Oct 1, 2026 · 4:00 PM EDT

Silexion Therapeutics (SLXN) Interest Expenses (2024 - 2025)

Updated

Silexion Therapeutics (SLXN) reported Interest Expenses of $13,000 for FY2025, down 51.9% from $27,000 in FY2024.

Analysis

Silexion Therapeutics (SLXN) Interest Expenses (2024 - 2025) Analysis & Trends

  • According to Business Quant data, Interest Expenses came in at $27,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Silexion Therapeutics 192,458.84 -19.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 11,000.00
Dec 31, 2024 27,000.00
API Access

Silexion Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=SLXN&period=max&api_key=YOUR_API_KEY